Exploring the Latest Data on Targeted Therapies for Treating gMG With Drs. Nicholas Silvestri and Kelly Gwathmey
In this podcast, expert clinicians will discuss the latest clinical data on targeted therapies for management of patients with gMG. To claim CE credit after listening to this episode, go to this link...
28 Helmi 202511min
Unraveling the Pathophysiology of gMG and Its Impact on Treatment Selection With Drs. Nicholas Silvestri and Carolina Barnett-Tapia
In this podcast, expert clinicians will discuss the pathophysiology of gMG and the significance of disease subtype on clinical decision-making. To claim CE credit after listening to this episode, go ...
28 Helmi 202511min
Understanding Disease Burden and Severity in gMG With Drs. Nicholas Silvestri and Neelam Goyal
In this podcast, expert clinicians will discuss the current tools for quantifying disease severity and burden in patients with gMG. To claim CE credit after listening to this episode, go to this link...
28 Helmi 202514min
Available and Novel Therapies for Nonmotor Symptoms in Parkinson's Disease With Drs. Pahwa and Armstrong
In this podcast, expert clinicians will discuss the available and novel therapies for nonmotor symptoms associated with Parkinson's disease.
31 Touko 202319min
Current and Emerging Treatment Options for Motor Symptoms in Parkinson's Disease With Drs. Rajesh Pahwa and Stuart Isaacson
In this podcast, expert clinicians will discuss the current and emerging therapies for motor symptoms in Parkinson's disease.
31 Touko 202315min
Staging and Monitoring Parkinson's Disease With Drs. Rajesh Pahwa and David Standaert
In this podcast, expert clinicians will discuss the challenges in the staging and monitoring of Parkinson's disease.
31 Touko 202315min
Differentiating Oral DMTs to Optimize Treatment Individualization with Drs. Stephen Krieger and Patricia K. Coyle
In this podcast, expert clinicians will revisit an important topic from MS Forum® VIII, the use of current and emerging oral therapies for MS, including the Burton's tyrosine kinase (BTK) inhibitors.
7 Joulu 202215min
